These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


165 related items for PubMed ID: 11467677

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Early obstructive colon after treatment of active refractory Crohn's disease with infliximab].
    Belaiche J, Louis E.
    Gastroenterol Clin Biol; 2003 Nov; 27(11):1045-7. PubMed ID: 14732856
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Indications and results of infliximab in Crohn's disease].
    Karoui S, Boubaker J, Filali A.
    Tunis Med; 2004 Dec; 82(12):1057-63. PubMed ID: 15822505
    [Abstract] [Full Text] [Related]

  • 6. Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis.
    Katz JA, Antoni C, Keenan GF, Smith DE, Jacobs SJ, Lichtenstein GR.
    Am J Gastroenterol; 2004 Dec; 99(12):2385-92. PubMed ID: 15571587
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Complications of infliximab therapy in children and adolescents affected by Crohn's disease.
    Diamanti A, Papadatou B, Knafelz D, Gambarara M, Ferretti F, Castro M.
    Am J Gastroenterol; 2003 Dec; 98(12):2812-3. PubMed ID: 14687847
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Induction of pustular lesions during infliximab therapy for Crohn's disease.
    Pérez-Pérez L, Caeiro JL, Fabeiro JM, Allegue F, Zulaica A.
    Acta Derm Venereol; 2008 Dec; 88(3):292-3. PubMed ID: 18480940
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Colon cancer after infliximab therapy for Crohn's disease in a young patient transplanted for primary sclerosing cholangitis.
    Peyrin-Biroulet L, Bressenot A, Chone L, Denjean P, Boissel P, Bigard MA, Bronowicki JP.
    Am J Gastroenterol; 2006 Nov; 101(11):2664-5. PubMed ID: 17090288
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Successful use of adalimumab (Humira) for Crohn's disease in pregnancy.
    Mishkin DS, Van Deinse W, Becker JM, Farraye FA.
    Inflamm Bowel Dis; 2006 Aug; 12(8):827-8. PubMed ID: 16917239
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.